Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

BACKGROUND: At present, immunotherapy has become an important treatment for lung cancer. With the widespread use of immune checkpoint inhibitors (ICIs), we must be strict with the emergence of immune related adverse events (irAEs). There are also some patients who do not respond to immunotherapy. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ni, Yi, Ye, Cao, Wen, Fu, Xiao, Mei, Nan, Li, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449836/
https://www.ncbi.nlm.nih.gov/pubmed/36091125
http://dx.doi.org/10.3389/fonc.2022.923531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449836/
https://www.ncbi.nlm.nih.gov/pubmed/36091125
http://dx.doi.org/10.3389/fonc.2022.923531

Ejemplares similares